![(−)-3,4,4a,5,6,10b-Hexahydro-9-methoxy-2H-naphtho[1,2-b][1,4]oxazin-3-one - chemical structure image](https://media.scbt.com/product/3-4-4a-5-6-10b-hexahydro-9-methoxy-2h-naphtho1-2-b1-4oxazin-3-one-structure_26_21_b_262151.jpg)
![(−)-3,4,4a,5,6,10b-Hexahydro-9-methoxy-2H-naphtho[1,2-b][1,4]oxazin-3-one - chemical structure image](https://media.scbt.com/product/3-4-4a-5-6-10b-hexahydro-9-methoxy-2h-naphtho1-2-b1-4oxazin-3-one-structure_26_21_t_262151.jpg "Molecular structure of (−)-3,4,4a,5,6,10b-Hexahydro-9-methoxy-2H-naphtho[1,2-b][1,4]oxazin-3-one")
Molecular structure of (−)-3,4,4a,5,6,10b-Hexahydro-9-methoxy-2H-naphtho[1,2-b][1,4]oxazin-3-one
(-)-3,4,4a,5,6,10b-Hexahydro-9-methoxy-2H-naphtho[1,2-b][1,4]oxazin-3-one
Application:
(−)-3,4,4a,5,6,10b-Hexahydro-9-methoxy-2H-naphtho[1,2-b][1,4]oxazin-3-one is a dopaminergic antagonist
Molecular Weight:
233.26
Molecular Formula:
C13H15NO3
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.
QUICK LINKS
Ordering Information
Description
Technical Information
Safety Information
SDS & Certificate of Analysis
A dopamine antagonist and dopaminergic ligand.
(-)-3,4,4a,5,6,10b-Hexahydro-9-methoxy-2H-naphtho[1,2-b][1,4]oxazin-3-one References
Dijkstra, D., et al.: J. Med. Chem., 45, 3022 (2002)Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
(-)-3,4,4a,5,6,10b-Hexahydro-9-methoxy-2H-naphtho[1,2-b][1,4]oxazin-3-one, 5 mg | sc-216587 | 5 mg | $300.00 |